Insider trade

Bio-Rad Laboratories (BIO): Officer sold ~$214K

James Barry, Officer at Bio-Rad Laboratories, sold ~$214K of Bio-Rad Laboratories shares.

~$214K
Approx. value · 699.87 sh @ $306.18
509.68
Holds after · shares reported
Traded
Nov 6, 2025
Filed
Nov 10, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 29, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  2. Nov 6, 2025 · this disclosureInsiderOfficer sold ~$214K of BIO shares in the open market

What came next

  1. Feb 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Bio-Rad Laboratories

For Bio-Rad Laboratories, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BIO page.

Other recent filings by James Barry, EVP, President, LSG

The full history of James Barry, EVP, President, LSG is on the profile page.

How this filing works

Explore the data

Other disclosures at Bio-Rad Laboratories

Everything OQRO holds on this company is on its BIO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data